期刊文献+

Percoll密度离心富集慢性粒细胞白血病DC前体细胞

Enrichment of dendritic cells precursor from chronic myelogeous leukemia by Percoll density gradients
下载PDF
导出
摘要 目的:建立一种有效、费用低的富集慢性粒细胞白血病树突状细胞(DC)前体细胞的方法。方法:Ficoll-Hypaque液常规分离慢性粒细胞白血病(CML)外周血单个核细胞,55%Percoll密度离心,比较Percoll分离后的低密度层细胞(B组)、高密度层细胞(C组)及未经Percoll分离细胞(A组)的细胞分类、诱导后CD1a、CD86表达。结果:55%Percoll混悬液分离后的B组细胞中早幼粒和中幼粒细胞所占百分比高于A组(P<0.05)和C组细胞(P<0.01),而淋巴细胞、嗜酸性粒细胞和嗜碱性粒细胞的百分比明显少于C组,较A组也有所减少。B组细胞经诱导14 d后CD1a、CD86阳性细胞百分率明显高于C组细胞和A组细胞(P<0.01)。结论:经55%Percoll混悬液分离外周血单个核细胞可提高DC诱导的比率,且该方法无毒、费用低、易操作、分离细胞数量大,可充分满足临床DC的回输需要。 Objective To set up an effective and low-price way for enriching dendritic cells precursor from chronic myelogeous leukemia by Percoll density gradients. Methods Peripheral blood mononuclear cells (PBMCs) were collected by separation through Ficoll-Hypaque, then PBMCs were separated by 55% Percoll gradients. The cell type and DCs expressing CDla, CD86 were detected in the high-density group (C) , low-density group (B) and non-Percoll separation group (A). Results After separation of 55% Percoll, the percentage of promyelocytes and myelocytes in group B was obviously higher than those in group A and group C (P〈0.01). Moreover the percentages of lymphocytes, eosinophilic granulocytes and basophilic granulocytes in group B were lower than those in group C and group A. The percentages of CDla and CD86 cells detected by FACS on 14th day in group B were higher than those in group A and group C (P〈0.01). Conclusion The induced rate of dendritic cells is improved after the separation of 55% Percoll. This method is no-toxic, cheap , simple and can handle a large number of cells. It' s useful for clinical application.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期102-104,共3页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅基金资助课题(20001108)
关键词 PERCOLL 富集 白血病 髓样 慢性 树突状细胞 Percoll density gradients enrichment leukemia, myeloid, chronic dendritic cells.
  • 相关文献

参考文献6

二级参考文献17

  • 1司图镇强.细胞培养[M].西安:世界图书出版西安公司,2000.186-187.
  • 2巴德年.当代免疫技术与应用[M].北京:北京医科大学,中国协合医科大学联合出版社,1998.205-206.
  • 3Fialknow PJ, Jacohan RJ, Papayannopoulou TH. Chronic myelocytic leukemia: clonal origin in stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage[J]. Am J Med, 1997, 63: 125-130.
  • 4Rowley J. The philadelpia chromosome translocation:aparadigm for understanding leukemia [J]. Cancer, 1990, 65 :2178-2184.
  • 5Choudhury A, Gajewski JL, Liang LC, et al. Use of leukemic dendritic cell for r the generation of antioleukemic cellular cytoxicity against Philadelphia chromosome positive chronic myelogenous leukemia[J].Blood,1997,89:1133-1142.
  • 6Hart DNJ. Dendritic cell: unique leukocyte population which control the primary immune response [J]. Blood, 1997, 90:3245-3287.
  • 7Oehler L, Majdic O, Pick WF, et al. Neutrophil Granulocytecommitted cells can be driven to acquire dendritic cell characteristics [J]. J Exp Med, 1998, 187: 1019-1028.
  • 8Steinman RM. The control of immunity and tolerance by dendritic cells [J]. Panthol Biol, 2003, 51 (2): 59-60.
  • 9Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cell: which signals induce tolerance or immunity [J].Trends Immunol, 2002, 23 (9): 445-449.
  • 10Menges M, Rossner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor-α induce antigen-specific protection of mice from autoimmunity [J]. J Exp Med, 2002, 195 (1): 15-21.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部